Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2024-08-27 00:00:00 ET · period of report 2024-08-26 · accession 0001493152-24-034054 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-27 | 2024-08-26 | ABEO | Charles Faith L. | Dir | A - Grant | $0.00 | +11.8K | 113.7K | +12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-26 | A | A | 11,797 | $0.00 | 113,731 | D | — | — | (F2) This stock grant represents the remainder of the 2024 annual grant to board of directors. This portion of the annual stock grant was withheld until all employees/management were allocated their shares and in order to enable onboarding of two new Board members. All of the restricted stock will vest on August 26, 2025. |